Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res June 15 2010 16 (12) 3089-3089;

CCR Translations

  • CCR Translations
    How to Train Your Biomarker
    Douglas Yee
    Clin Cancer Res June 15 2010 16 (12) 3091-3093; DOI:10.1158/1078-0432.CCR-10-0873

Molecular Pathways

  • Molecular Pathways
    Inhibition of the PI3K Pathway: Hope We Can Believe in?
    Michiel S. van der Heijden and René Bernards
    Clin Cancer Res June 15 2010 16 (12) 3094-3099; DOI:10.1158/1078-0432.CCR-09-3004

  • Molecular Pathways
    Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
    Laurence Zitvogel, Oliver Kepp, Laura Senovilla, Laurie Menger, Nathalie Chaput and Guido Kroemer
    Clin Cancer Res June 15 2010 16 (12) 3100-3104; DOI:10.1158/1078-0432.CCR-09-2891

CCR Focus

  • CCR Focus
    Drugs That Target the Stemness Pathways
    Susan E. Bates
    Clin Cancer Res June 15 2010 16 (12) 3105-3105; DOI:10.1158/1078-0432.CCR-10-1127

  • CCR Focus
    Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways
    Naoko Takebe and S. Percy Ivy
    Clin Cancer Res June 15 2010 16 (12) 3106-3112; DOI:10.1158/1078-0432.CCR-09-2934

  • CCR Focus
    Cancer Stem Cells and Self-renewal
    Catherine Adell O'Brien, Antonija Kreso and Catriona H.M. Jamieson
    Clin Cancer Res June 15 2010 16 (12) 3113-3120; DOI:10.1158/1078-0432.CCR-09-2824

  • CCR Focus
    The Difficulty of Targeting Cancer Stem Cell Niches
    Mark A. LaBarge
    Clin Cancer Res June 15 2010 16 (12) 3121-3129; DOI:10.1158/1078-0432.CCR-09-2933

  • CCR Focus
    Targeting Hedgehog — a Cancer Stem Cell Pathway
    Akil A. Merchant and William Matsui
    Clin Cancer Res June 15 2010 16 (12) 3130-3140; DOI:10.1158/1078-0432.CCR-09-2846

  • CCR Focus
    Targeting Notch to Target Cancer Stem Cells
    Antonio Pannuti, Kimberly Foreman, Paola Rizzo, Clodia Osipo, Todd Golde, Barbara Osborne and Lucio Miele
    Clin Cancer Res June 15 2010 16 (12) 3141-3152; DOI:10.1158/1078-0432.CCR-09-2823

  • CCR Focus
    Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
    Fumi Takahashi-Yanaga and Michael Kahn
    Clin Cancer Res June 15 2010 16 (12) 3153-3162; DOI:10.1158/1078-0432.CCR-09-2943

Human Cancer Biology

  • Human Cancer Biology
    Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis
    Akihiko Kawahara, Chizuko Yamamoto, Kazutaka Nakashima, Koichi Azuma, Satoshi Hattori, Masaki Kashihara, Hisamichi Aizawa, Yuji Basaki, Michihiko Kuwano, Masayoshi Kage, Tetsuya Mitsudomi and Mayumi Ono
    Clin Cancer Res June 15 2010 16 (12) 3163-3170; DOI:10.1158/1078-0432.CCR-09-3239

  • Human Cancer Biology
    Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2
    Gong Yang, Bin Chang, Fan Yang, Xiaoqing Guo, Kathy Qi Cai, Xue (Sherry) Xiao, Huamin Wang, Subrata Sen, Mien-Chie Hung, Gordon B. Mills, Sandy Chang, Asha S. Multani, Imelda Mercado-Uribe and Jinsong Liu
    Clin Cancer Res June 15 2010 16 (12) 3171-3181; DOI:10.1158/1078-0432.CCR-09-3171

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma
    Qing Liu, Lapo Alinari, Ching-Shih Chen, Fengting Yan, James T. Dalton, Rosa Lapalombella, Xiaoli Zhang, Rajeswaran Mani, Teresa Lin, John C. Byrd, Robert A. Baiocchi and Natarajan Muthusamy
    Clin Cancer Res June 15 2010 16 (12) 3182-3192; DOI:10.1158/1078-0432.CCR-09-2484

  • Cancer Therapy: Preclinical
    Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development
    Todd M. Pitts, Aik Choon Tan, Gillian N. Kulikowski, John J. Tentler, Amy M. Brown, Sara A. Flanigan, Stephen Leong, Christopher D. Coldren, Fred R. Hirsch, Marileila Varella-Garcia, Christopher Korch and S. Gail Eckhardt
    Clin Cancer Res June 15 2010 16 (12) 3193-3204; DOI:10.1158/1078-0432.CCR-09-3191

  • Cancer Therapy: Preclinical
    Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy
    Joseph N. Contessa, Mahaveer S. Bhojani, Hudson H. Freeze, Brian D. Ross, Alnawaz Rehemtulla and Theodore S. Lawrence
    Clin Cancer Res June 15 2010 16 (12) 3205-3214; DOI:10.1158/1078-0432.CCR-09-3331

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis | Free Article
    Drug-Induced Vessel Remodeling in Bone Metastases as Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging and Vessel Size Imaging: A Longitudinal In vivo Study
    Tobias Bäuerle, Maximilian Merz, Dorde Komljenovic, Stefan Zwick and Wolfhard Semmler
    Clin Cancer Res June 15 2010 16 (12) 3215-3225; DOI:10.1158/1078-0432.CCR-09-2932

  • Imaging, Diagnosis, Prognosis
    Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC
    Nita Amornsiripanitch, Shaolin Hong, Michael J. Campa, Michael M. Frank, Elizabeth B. Gottlin and Edward F. Patz Jr.
    Clin Cancer Res June 15 2010 16 (12) 3226-3231; DOI:10.1158/1078-0432.CCR-10-0321

  • Imaging, Diagnosis, Prognosis
    A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam
    Andrew J. Vickers, Angel M. Cronin, Monique J. Roobol, Caroline J. Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Fritz H. Schröder and Hans Lilja
    Clin Cancer Res June 15 2010 16 (12) 3232-3239; DOI:10.1158/1078-0432.CCR-10-0122

  • Imaging, Diagnosis, Prognosis
    HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
    Till Milde, Ina Oehme, Andrey Korshunov, Annette Kopp-Schneider, Marc Remke, Paul Northcott, Hedwig E. Deubzer, Marco Lodrini, Michael D. Taylor, Andreas von Deimling, Stefan Pfister and Olaf Witt
    Clin Cancer Res June 15 2010 16 (12) 3240-3252; DOI:10.1158/1078-0432.CCR-10-0395

  • Imaging, Diagnosis, Prognosis
    Overexpression of p73 as a Tissue Marker for High-Risk Gastritis
    Gonzalo Carrasco, Jose Diaz, Jose R. Valbuena, Paulina Ibanez, Paz Rodriguez, Gabriela Araya, Carolina Rodriguez, Javiera Torres, Ignacio Duarte, Edmundo Aravena, Fernando Mena, Carlos Barrientos and Alejandro H. Corvalan
    Clin Cancer Res June 15 2010 16 (12) 3253-3259; DOI:10.1158/1078-0432.CCR-09-2491

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma
    María Victoria Mateos, Maria Teresa Cibeira, Paul G. Richardson, Felipe Prosper, Albert Oriol, Javier de la Rubia, Juan José Lahuerta, Ramón García-Sanz, Sonia Extremera, Sergio Szyldergemajn, Claudia Corrado, Harald Singer, Constantine S. Mitsiades, Kenneth C. Anderson, Joan Bladé and Jesús San Miguel
    Clin Cancer Res June 15 2010 16 (12) 3260-3269; DOI:10.1158/1078-0432.CCR-10-0469

  • Cancer Therapy: Clinical
    Biobehavioral, Immune, and Health Benefits following Recurrence for Psychological Intervention Participants
    Barbara L. Andersen, Lisa M. Thornton, Charles L. Shapiro, William B. Farrar, Bethany L. Mundy, Hae-Chung Yang and William E. Carson III
    Clin Cancer Res June 15 2010 16 (12) 3270-3278; DOI:10.1158/1078-0432.CCR-10-0278

  • Cancer Therapy: Clinical
    AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
    Per-Uno Malmström, Angelica S.I. Loskog, Camilla A. Lindqvist, Sara M. Mangsbo, Moa Fransson, Alkwin Wanders, Truls Gårdmark and Thomas H. Tötterman
    Clin Cancer Res June 15 2010 16 (12) 3279-3287; DOI:10.1158/1078-0432.CCR-10-0385

  • Cancer Therapy: Clinical
    Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients
    Delphine Kérob, Raphael Porcher, Olivier Vérola, Stephane Dalle, Eve Maubec, François Aubin, Michel D'Incan, Isaak Bodokh, Serge Boulinguez, Isabelle Madelaine-Chambrin, Anne Mathieu-Boue, Jean-Marie Servant, Eric de Kerviler, Anne Janin, Fabien Calvo, Florence Pedeutour and Celeste Lebbe
    Clin Cancer Res June 15 2010 16 (12) 3288-3295; DOI:10.1158/1078-0432.CCR-09-3401

Back to top
PreviousNext
Clinical Cancer Research: 16 (12)
June 2010
Volume 16, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Inhibition of the PI3K Pathway: Hope We Can Believe in?
  • Drugs That Target the Stemness Pathways
  • Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development
  • Overexpression of p73 as a Tissue Marker for High-Risk Gastritis

Jump to

  • Highlights
  • CCR Translations
  • Molecular Pathways
  • CCR Focus
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement